Coexpression of vascular endothelial growth factor and p53 protein in squamous cell carcinoma of the esophagus

American Journal of Gastroenterology

Volumn 96, Issue 6, 2001, Pages 1733-1740

  Koide, Naohiko ^a   Nishio, Akihito ^a   Hiraguri, Manabu ^a   Hanazaki, Kazuhiro ^a   Adachi, Wataru ^a   Amano, Jun ^a  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

MONOCLONAL ANTIBODY KI 67; PROTEIN P53; VASCULOTROPIN; VON WILLEBRAND FACTOR;

ADULT; ANGIOGENESIS; APOPTOSIS; ARTICLE; CANCER SURVIVAL; CLINICAL FEATURE; CONTROLLED STUDY; ESOPHAGUS CARCINOMA; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LABELING INDEX; MAJOR CLINICAL STUDY; MALE; METASTASIS; NICK END LABELING; PRIORITY JOURNAL; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA;

APOPTOSIS; CAPILLARIES; CARCINOMA, SQUAMOUS CELL; ENDOTHELIAL GROWTH FACTORS; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; LYMPHOKINES; MALE; MIDDLE AGED; NEOPLASM METASTASIS; NEOVASCULARIZATION, PATHOLOGIC; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0034972705     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9270(01)02429-7     Document Type: Article

References (33)

1. What is the evidence that tumors are angiogenesis dependent?
2. Angiogenesis
3. Isolation and characterization of a vascular endothelial cell mitogen produced by pituitary-derived folliculo stellate cells
4. Vascular endothelial growth factor is a secreted angiogenic mitogen
5. Vascular endothelial growth factor expression in primary esophageal squamous cell carcinoma: Association with angiogenesis and tumor progression
6. Histochemical study of vascular endothelial growth factor in squamous cell carcinoma of the esophagus
7. Frequent mutation of the p53 gene in human esophageal cancer
8. Accumulation of p53 tumor suppressor gene protein: An independent marker of prognosis in breast cancer
9. The prognostic significance of the accumulation of p53 tumor suppressor gene protein in gastric adenocarcinoma
10. Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1
11. Release of an inhibitor of angiogenesis upon induction of wild type p53 expression in glioblastoma cells
12. Mutant p53 potentiates proteinkinase C induction of vascular endothelial growth factor expression
13. Wild-type p53 and v-Src exert opposing influence on human vascular endothelial growth factor gene expression
14. Combined analysis of p53 and vascular endothelial growth factor expression in colorectal carcinoma for determination of tumor vascularity and liver metastasis
15. Relationship of tumor angiogenesis and p53 accumulation in invasive bladder cancer
16. Tumor angiogenesis and metastasis. Correlation in invasive breast carcinoma
17. Tumor angiogenesis as a predictor of recurrence in gastric carcinoma
18. New Ki-67 equivalent murine monoclonal antibodies (MIB-1-3) prepared against recombinant parts of Ki-67 antigen
19. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation
20. Suppression of human colorectal carcinoma cell growth by wild-type p53
21. Participation of p53 protein in the cellular response to DNA damage
22. p53 guardian of the genome
23. Prognostic value of vascular endothelial growth factor expression in gastric carcinoma
24. In oesophageal squamous cell carcinoma vascular endothelial growth factor is associated with p53 mutation, advanced stage and poor prognosis
25. Dormancy of micrometastasis: Balanced proliferation and apoptosis in the presence of angiogenesis suppression
26. Spontaneous apoptosis is inversely related to intratumoral microvessel density in gastric carcinoma
27. Significance of p53 expression as a prognostic factor in oesophageal squamous cell carcinoma
28. p53 mutation and protein accumulation during multistage human esophageal carcinogenesis
29. p53 protein expression and prognosis in squamous cell carcinoma of the esophagus
30. Clinicopathologic significance of the expression of mutant p53 protein and the proliferative activity of cancer cells in patients with esophageal squamous cell carcinoma
31. Acceleration of proliferative activity of esophageal squamous cell carcinoma with invasion beyond the mucosa: Immunohistochemical analysis of Ki-67 and p53 antigen in relation to histopathologic findings
32. Expression of p53 protein in colorectal cancer and its relationship to short-term prognosis